About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Insights into Anti-cancer Medications

by Colleen Fleiss on April 29, 2018 at 1:59 AM
Font : A-A+

New Insights into Anti-cancer Medications

New study assessed whether the clinical benefits of novel anticancer drugs have increased over time in parallel with increasing pricing. The authors of The Journal of Oncology Practice paper (1) used both the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) (2) and ASCO's Value Framework concluded while costs of these have risen over the past decade, their clinical benefit has not improved proportionally.

The ESMO-MCBS uses a rational, structured and consistent approach to grade the magnitude of clinical benefit that can be expected from anticancer treatments.

Advertisement


Prof. Elisabeth de Vries, Chair of the ESMO Cancer Medicines Committee and the ESMO-MCBS Working Group, (3) said: "The ESMO-MCBS provides unbiased information to help guide physicians and decision makers to grade drugs newly approved by the European Medicines Agency (EMA) by assessing their clinical benefit. It is an important first step in the major and ongoing task of evaluating value in cancer care which is essential for the appropriate use of limited public funds in delivering cost-effective and more affordable cancer care."

Prof. Josep Tabernero, ESMO President, said: "Access to anticancer medicines is an essential component of high quality cancer care, hence affordability is crucial in providing optimal treatment and patient care." There are however many additional critical factors. "Other major considerations include the availability of highly trained oncologists, up-to-the-minute diagnostics, the necessary funding and frameworks in place for research, a holistic approach to cancer care incorporating supportive and palliative care, and a multidisciplinary approach to best manage and treat our patients," continued Tabernero.
Advertisement

"ESMO calls for a multi-stakeholder commitment towards ultimately ensuring access to optimal cancer care for all patients," said Tabernero. "Sustainable cancer care is a key pillar of the ESMO 2020 Vision (4) and we are determined to continue pursuing this goal in collaboration with our partners."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Top 10 Health Benefits of Cloves 

Recommended Reading
Chemotherapy Drugs
Chemotherapy drugs perform like 'magic bullets' to destroy cancer cells in the body....
Quiz on Cancer
Cancer, is the second most leading cause of death worldwide. Cancer is not just one disease but ......
Lifetime Risk Calculator for Cancers
What are your chances for developing some common cancers in your lifetime - find out now....
Cancer Prevention thro' Lifestyle Changes
Did u know that simple changes in lifestyle could lower your cancer risks? Find out how!...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Top 10 Health Benefits of Cloves
Clove doesn’t just enhance the flavor of food, but, keeps your health in check by keeping diabetes, ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use